UniProt ID | TRI41_HUMAN | |
---|---|---|
UniProt AC | Q8WV44 | |
Protein Name | E3 ubiquitin-protein ligase TRIM41 | |
Gene Name | TRIM41 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 630 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Functions as an E3 ligase that catalyzes the ubiquitin-mediated degradation of protein kinase C.. | |
Protein Sequence | MAAVAMTPNPVQTLQEEAVCAICLDYFTDPVSIGCGHNFCRVCVTQLWGGEDEEDRDELDREEEEEDGEEEEVEAVGAGAGWDTPMRDEDYEGDMEEEVEEEEEGVFWTSGMSRSSWDNMDYVWEEEDEEEDLDYYLGDMEEEDLRGEDEEDEEEVLEEVEEEDLDPVTPLPPPPAPRRCFTCPQCRKSFPRRSFRPNLQLANMVQVIRQMHPTPGRGSRVTDQGICPKHQEALKLFCEVDEEAICVVCRESRSHKQHSVVPLEEVVQEYKAKLQGHVEPLRKHLEAVQKMKAKEERRVTELKSQMKSELAAVASEFGRLTRFLAEEQAGLERRLREMHEAQLGRAGAAASRLAEQAAQLSRLLAEAQERSQQGGLRLLQDIKETFNRCEEVQLQPPEVWSPDPCQPHSHDFLTDAIVRKMSRMFCQAARVDLTLDPDTAHPALMLSPDRRGVRLAERRQEVADHPKRFSADCCVLGAQGFRSGRHYWEVEVGGRRGWAVGAARESTHHKEKVGPGGSSVGSGDASSSRHHHRRRRLHLPQQPLLQREVWCVGTNGKRYQAQSSTEQTLLSPSEKPRRFGVYLDYEAGRLGFYNAETLAHVHTFSAAFLGERVFPFFRVLSKGTRIKLCP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
84 | Phosphorylation | GAGAGWDTPMRDEDY CCCCCCCCCCCCCCC | 16.69 | 24275569 | |
115 | Phosphorylation | WTSGMSRSSWDNMDY ECCCCCCCHHCCCCC | 28.59 | 24275569 | |
116 | Phosphorylation | TSGMSRSSWDNMDYV CCCCCCCHHCCCCCC | 37.02 | 24275569 | |
155 (in isoform 3) | Ubiquitination | - | 50.81 | 21906983 | |
194 | Phosphorylation | RKSFPRRSFRPNLQL HHHCCCCCCCCCHHH | 27.21 | 28555341 | |
214 | Phosphorylation | VIRQMHPTPGRGSRV HHHHHCCCCCCCCCC | 24.56 | 22210691 | |
219 | Phosphorylation | HPTPGRGSRVTDQGI CCCCCCCCCCCCCCC | 23.40 | - | |
229 | Ubiquitination | TDQGICPKHQEALKL CCCCCCCCHHHHHHH | 54.21 | - | |
235 | Ubiquitination | PKHQEALKLFCEVDE CCHHHHHHHHEECCC | 46.71 | - | |
256 | Sumoylation | CRESRSHKQHSVVPL EECCCCCCCCCEECH | 51.45 | 25218447 | |
256 | Ubiquitination | CRESRSHKQHSVVPL EECCCCCCCCCEECH | 51.45 | 29967540 | |
256 | Sumoylation | CRESRSHKQHSVVPL EECCCCCCCCCEECH | 51.45 | - | |
271 | Ubiquitination | EEVVQEYKAKLQGHV HHHHHHHHHHHCCCC | 37.99 | - | |
273 | Sumoylation | VVQEYKAKLQGHVEP HHHHHHHHHCCCCHH | 36.87 | - | |
273 | Ubiquitination | VVQEYKAKLQGHVEP HHHHHHHHHCCCCHH | 36.87 | 29967540 | |
273 | Sumoylation | VVQEYKAKLQGHVEP HHHHHHHHHCCCCHH | 36.87 | - | |
283 | Ubiquitination | GHVEPLRKHLEAVQK CCCHHHHHHHHHHHH | 61.29 | 29967540 | |
290 | Ubiquitination | KHLEAVQKMKAKEER HHHHHHHHHHHHHHH | 35.45 | 29967540 | |
303 | Succinylation | ERRVTELKSQMKSEL HHHHHHHHHHHHHHH | 32.20 | 23954790 | |
303 | Ubiquitination | ERRVTELKSQMKSEL HHHHHHHHHHHHHHH | 32.20 | 22817900 | |
307 (in isoform 4) | Ubiquitination | - | 32.89 | 21906983 | |
307 (in isoform 2) | Ubiquitination | - | 32.89 | 21906983 | |
307 (in isoform 1) | Ubiquitination | - | 32.89 | 21906983 | |
307 | Ubiquitination | TELKSQMKSELAAVA HHHHHHHHHHHHHHH | 32.89 | 22817900 | |
308 | Phosphorylation | ELKSQMKSELAAVAS HHHHHHHHHHHHHHH | 32.28 | 22210691 | |
315 | Phosphorylation | SELAAVASEFGRLTR HHHHHHHHHHHHHHH | 27.19 | 22210691 | |
321 | Phosphorylation | ASEFGRLTRFLAEEQ HHHHHHHHHHHHHHH | 20.29 | 22210691 | |
383 | Ubiquitination | LRLLQDIKETFNRCE HHHHHHHHHHHHCCC | 60.02 | 21906983 | |
383 (in isoform 2) | Ubiquitination | - | 60.02 | 21906983 | |
383 (in isoform 1) | Ubiquitination | - | 60.02 | 21906983 | |
401 | Phosphorylation | LQPPEVWSPDPCQPH CCCCCCCCCCCCCCC | 25.30 | 25159151 | |
434 | Phosphorylation | QAARVDLTLDPDTAH HHHCCCCEECCCCCC | 25.34 | 28450419 | |
439 | Phosphorylation | DLTLDPDTAHPALML CCEECCCCCCCHHHC | 32.05 | 22617229 | |
447 | Phosphorylation | AHPALMLSPDRRGVR CCCHHHCCCCHHCCH | 15.70 | 22617229 | |
512 | Ubiquitination | ESTHHKEKVGPGGSS CCCCCCCCCCCCCCC | 58.24 | 22505724 | |
518 | Phosphorylation | EKVGPGGSSVGSGDA CCCCCCCCCCCCCCC | 27.97 | - | |
519 | Phosphorylation | KVGPGGSSVGSGDAS CCCCCCCCCCCCCCC | 33.50 | - | |
522 | Phosphorylation | PGGSSVGSGDASSSR CCCCCCCCCCCCCCC | 31.20 | 21815630 | |
526 | Phosphorylation | SVGSGDASSSRHHHR CCCCCCCCCCCCHHH | 33.32 | 21815630 | |
528 | Phosphorylation | GSGDASSSRHHHRRR CCCCCCCCCCHHHCH | 32.89 | 21815630 | |
557 | Sumoylation | WCVGTNGKRYQAQSS EEEECCCCEEEECCC | 50.42 | - | |
557 | Sumoylation | WCVGTNGKRYQAQSS EEEECCCCEEEECCC | 50.42 | - | |
557 | Ubiquitination | WCVGTNGKRYQAQSS EEEECCCCEEEECCC | 50.42 | - | |
563 | Phosphorylation | GKRYQAQSSTEQTLL CCEEEECCCCCCCCC | 42.09 | 30108239 | |
564 | Phosphorylation | KRYQAQSSTEQTLLS CEEEECCCCCCCCCC | 24.71 | 30108239 | |
565 | Phosphorylation | RYQAQSSTEQTLLSP EEEECCCCCCCCCCC | 37.04 | 30108239 | |
568 | Phosphorylation | AQSSTEQTLLSPSEK ECCCCCCCCCCCCCC | 24.35 | 30108239 | |
571 | Phosphorylation | STEQTLLSPSEKPRR CCCCCCCCCCCCCCE | 29.50 | 25849741 | |
573 | Phosphorylation | EQTLLSPSEKPRRFG CCCCCCCCCCCCEEE | 55.68 | 30108239 | |
575 | Ubiquitination | TLLSPSEKPRRFGVY CCCCCCCCCCEEEEE | 48.43 | 22817900 | |
575 (in isoform 1) | Ubiquitination | - | 48.43 | 21906983 | |
582 | Phosphorylation | KPRRFGVYLDYEAGR CCCEEEEEEEECCCC | 8.34 | 20860994 | |
585 | Phosphorylation | RFGVYLDYEAGRLGF EEEEEEEECCCCEEE | 12.70 | 20860994 | |
621 | Phosphorylation | FPFFRVLSKGTRIKL HHHHHHCCCCCCEEE | 26.61 | 30622161 | |
624 | Phosphorylation | FRVLSKGTRIKLCP- HHHCCCCCCEEECC- | 32.72 | 30622161 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRI41_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRI41_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRI41_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-447, AND MASSSPECTROMETRY. |